Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial-Reference-Cited by-同舟云学术

Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial

Published:2010-11 Issue:9753 Volume:376 Page:1682-1688
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Sutter Roland W,John T Jacob,Jain Hemant,Agarkhedkar Sharad,Ramanan Padmasani Venkat,Verma Harish,Deshpande Jagadish,Singh Ajit Pal,Sreevatsava Meghana,Malankar Pradeep,Burton Anthony,Chatterjee Arani,Jafari Hamid,Aylward R Bruce

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Global eradication of poliomyelitis by the year 2000,1988

2. Progress towards interrupting wild poliovirus transmission worldwide, 2009;Wkly Epidemiol Rec,2010

3. Progress towards poliomyelitis eradication: India, January 2007–May 2009;Wkly Epidemiol Rec,2009

4. Progress towards poliomyelitis eradication in Afghanistan and Pakistan, 2008;Wkly Epidemiol Rec,2009

5. Effectiveness of immunization against paralytic poliomyelitis in Nigeria;Jenkins;N Engl J Med,2008

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nutritional Status Link with Polioseronegativity Among Children from Poliomyelitis Transmission High-Risk Area of the Democratic Republic of the Congo (DRC);Journal of Multidisciplinary Healthcare;2024-03

2. Prediction Model with Validation for Polioseronegativity in Malnourished Children from Poliomyelitis Transmission High-Risk Area of the Democratic Republic of the Congo (DRC);Pragmatic and Observational Research;2023-12

3. Poliovirus type 1 systemic humoral and intestinal mucosal immunity induced by monovalent oral poliovirus vaccine, fractional inactivated poliovirus vaccine, and bivalent oral poliovirus vaccine: A randomized controlled trial;Vaccine;2023-09

4. Does IPV Boost Intestinal Immunity among Children under Five Years of Age? An Experience from Pakistan;Vaccines;2023-09-01

5. Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial;The Lancet Infectious Diseases;2023-09